BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23304015)

  • 1. Extreme thrombocytosis and cardiovascular surgery: risks and management.
    Natelson EA
    Tex Heart Inst J; 2012; 39(6):792-8. PubMed ID: 23304015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
    Michiels JJ; van Genderen PJ; Lindemans J; van Vliet HH
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():47-56. PubMed ID: 8951772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role for platelet apheresis for post-liver transplant thrombocytosis complicating portal vein thrombosis.
    Au WY; Liu CL; Lo CM; Fan ST; Ma SK
    J Clin Apher; 2004; 19(4):192-6. PubMed ID: 15597348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding and thrombosis in the myeloproliferative disorders.
    Schafer AI
    Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
    Michiels JJ
    Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
    Boddu P; Falchi L; Hosing C; Newberry K; Bose P; Verstovsek S
    Leuk Res; 2017 Jul; 58():14-22. PubMed ID: 28380402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plateletpheresis: Nonoperative Management of Symptomatic Carotid Thrombosis in a Patient with Reactive Thrombocytosis.
    Martínez RC; Quaynor S; Alkhalifah M; Goldenberg FD
    World Neurosurg; 2018 Jun; 114():126-129. PubMed ID: 29555611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for essential thrombocythemia and polycythemia vera.
    Solberg LA
    Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of thrombosis in essential thrombocythemia and polycythemia vera.
    Pearson TC
    Semin Oncol; 2002 Jun; 29(3 Suppl 10):16-21. PubMed ID: 12096353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary thrombocythemia: a current perspective.
    Mughal TI
    Stem Cells; 1995 Jul; 13(4):355-9. PubMed ID: 7549894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis and Thrombosis: Is There Really a Correlation?
    Galvez C; Stein BL
    Curr Hematol Malig Rep; 2020 Aug; 15(4):261-267. PubMed ID: 32399765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of blood component removal in essential and reactive thrombocytosis.
    Greist A
    Ther Apher; 2002 Feb; 6(1):36-44. PubMed ID: 11886575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases).
    Randi ML; Stocco F; Rossi C; Tison T; Girolami A
    J Med; 1991; 22(4-5):213-23. PubMed ID: 1787383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):247-51. PubMed ID: 10726022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera].
    Tekin M; Gökaslan S; Diker E; Aydoğdu S
    Turk Kardiyol Dern Ars; 2008 Jan; 36(1):35-8. PubMed ID: 18453785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytosis and thrombosis.
    Vannucchi AM; Barbui T
    Hematology Am Soc Hematol Educ Program; 2007; ():363-70. PubMed ID: 18024652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
    Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
    Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.